Guardant Health, Inc.

Services-Medical Laboratories·PALO ALTO, CA·FY end 12/31·CIK 1576280

CEO Pay Ratio

44:1

AmirAli Talasaz

CEO Total Comp

—

AmirAli Talasaz

Median Employee

$198,418

Revenue

$982.0M

FY 2025

Net Income

-$416.3M

FY 2025

Free Cash Flow

-$233.1M

FY 2025

Net Margin

-42.4%

Insider Net (180d)

-$395.6K

0 buys / 3 sales

CEO Pay Accountability

CEO comp as % of net income

—

Not enough data to compute.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$982.0M	$739.0M	$563.9M	$449.5M	$373.7M
Gross Profit	—	—	—	—	—	—
Operating Income	-$437.2M	-$443.6M	-$564.7M	-$544.4M	-$411.0M
Net Income	-$416.3M	-$436.4M	-$479.4M	—	—
Operating CF	-$184.8M	-$239.9M	-$325.0M	-$309.5M	-$209.0M
Capex	$48.3M	$35.1M	$20.5M	$77.5M	$75.0M
Free Cash Flow	-$233.1M	-$274.9M	-$345.5M	-$386.9M	-$284.1M
Buybacks	$45.0M	—	—	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	-44.5%	-60.0%	-100.1%	-121.1%	-110.0%
Net Margin	-42.4%	-59.0%	-85.0%	—	—
FCF Margin	-23.7%	-37.2%	-61.3%	-86.1%	-76.0%
R&D / Revenue	37.1%	47.1%	65.1%	83.2%	70.4%
Effective Tax	0.3%	-0.3%	-0.1%	-0.2%	-0.1%
Debt / Equity	-15.14	—	—	—	—	—
Buybacks / FCF	-19.3%	—	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
AmirAli TalasazCo-Chief Executive Officer	—	—	—	$8.7M	$8.7M	$8.7M
Helmy EltoukhyChairman and Co-Chief · CEO	—	—	—	$8.7M	$8.7M	$8.7M
Michael BellChief Financial Officer	$566.2K	$1.9M	$907.1K	$399.0K	$10.9K	$3.8M
Darya ChudovaChief Technology Officer	$520.2K	$1.8M	$824.6K	$377.5K	$10.7K	$3.5M
John SaiaChief Legal Officer	$527.1K	$1.5M	$725.7K	$376.0K	$11.3K	$3.2M
Craig EagleChief Medical Officer	$576.2K	$1.4M	$659.7K	$314.5K	$15.0K	$3.0M